<DOC>
	<DOCNO>NCT02236897</DOCNO>
	<brief_summary>This pilot study evaluate potential imaging biomarker aid diagnosis monitoring progression ALS , base well establish basic science pathway , publish human autopsy data , preliminary data ALS mutant mouse , recently publish data use brain PET scan image metabotropic glutamate receptor type 5 ( mGluR5 ) healthy human volunteer .</brief_summary>
	<brief_title>PET Imaging ALS Patients</brief_title>
	<detailed_description />
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Motor Neuron Disease</mesh_term>
	<mesh_term>Amyotrophic Lateral Sclerosis</mesh_term>
	<criteria>Male female ALS patient , range age 1880 . Must meet El Escorial Criteria Probable Definite ALS . Disease duration &gt; 1 year , &lt; 3 year . Weakness least two extremity . Forced vital capacity le 80 % great 50 % . Documented orthopnea otherwise unable lie flat PET scanner 90 minute . Presence pacemaker , aneurysm clip , shrapnel , implant metallic device would preclude MRI scan . Absence sufficient collateral arterial circulation radial arterial line placement wrist . Significant abnormality hepatic renal function , illicit substance use . Positive drug screen . ( Subjects currently take prescribe narcotic medication positive drug screen medication exclude . Medication history obtain screen ) . Weighs &gt; 350 lb .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>